Pronóstico perinatal y de la paciente embarazada con infección por COVID-19

Romero, David; Pérez, Juan Ocampo; Bautista, Liza; Santana-Cabrera, L.

doi:10.1016/j.rce.2020.04.006

Cited by 22 publications

(6 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, 24 studies, including a total of 324 pregnant women with COVID-19, met the eligibility criteria and were included in the review. These comprised nine case series 11,[19][20][21][22][23][24][25][26] , published between 4 March 2020 and 28 April 2020, and 15 case reports [27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] , published between 25 March 2020 and 28 April 2020 ( 35 1 I r a n 2 7 1 0 3 0+ 3 1 1 0 0 0 1 0 Kelly (2020) 36 1 U S A N R 1 0 3 3 1 1 0 0 0 0 0 Lee (2020) 37 1 Korea 28 1 0 37 + 6 1 1 0 0 1 0 0 Lowe (2020) 38 1 Australia 31 1 0 40 + 2 1 1 0 0 0 0 0 Schnettler (2020) 39 1 reported on a total of 295 pregnant patients 11,19,[21][22][23][24][25][26] . Of these, 211 (71.5%) cases had laboratory-confirmed and 84 (28.5%) had clinically diagnosed COVID-19.…”

Section: Figure 1 Summarizes the Selection Of Articles For Inclusionmentioning

confidence: 99%

“…Of these, 211 (71.5%) cases had laboratory-confirmed and 84 (28.5%) had clinically diagnosed COVID-19. The 15 case reports [27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] included a total of 20 pregnant patients with laboratory-confirmed COVID-19. We recorded data related to maternal and perinatal characteristics, and the clinical manifestations of COVID-19 at admission, including laboratory testing, treatment received and maternal, perinatal and neonatal outcome.…”

Section: Figure 1 Summarizes the Selection Of Articles For Inclusionmentioning

confidence: 99%

“…We recorded data related to maternal and perinatal characteristics, and the clinical manifestations of COVID-19 at admission, including laboratory testing, treatment received and maternal, perinatal and neonatal outcome. The majority of the cases originated from China 11,[21][22][23][24][25] , but cases from Australia (one case report) 38 , Canada and France (one case report) 40 , Korea (one case report) 37 , Iran (two case reports and one case series) 20,35,41 , Italy (one case series and one case report) 26,29 , Peru (one case report) , Spain (two case reports) 27,31 , Sweden (one case report) 30 , Turkey (one case report) 34 and USA (one case series and four case reports) 19,32,33,36,39 were also included. We differentiated cases that were laboratory-confirmed from those that were diagnosed clinically, but data from the two types of diagnosis were combined for presentation.…”

Section: Figure 1 Summarizes the Selection Of Articles For Inclusionmentioning

confidence: 99%

See 2 more Smart Citations

Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome: systematic review

Juan

Gil

Zeng

et al. 2020

Ultrasound in Obstet & Gyne

507

501

View full text Add to dashboard Cite

Objective To evaluate the effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome by performing a systematic review of available published literature on pregnancies affected by COVID‐19. Methods We performed a systematic review to evaluate the effect of COVID‐19 on pregnancy, perinatal and neonatal outcome. We conducted a comprehensive literature search using PubMed, EMBASE, the Cochrane Library, China National Knowledge Infrastructure Database and Wan Fang Data up to and including 20 April 2020 (studies were identified through PubMed alert after that date). For the search strategy, combinations of the following keywords and medical subject heading (MeSH) terms were used: ‘SARS‐CoV‐2’, ‘COVID‐19’, ‘coronavirus disease 2019’, ‘pregnancy’, ‘gestation’, ‘maternal’, ‘mother’, ‘vertical transmission’, ‘maternal–fetal transmission’, ‘intrauterine transmission’, ‘neonate’, ‘infant’ and ‘delivery’. Eligibility criteria included laboratory‐confirmed and/or clinically diagnosed COVID‐19, patient being pregnant on admission and availability of clinical characteristics, including at least one maternal, perinatal or neonatal outcome. Exclusion criteria were non‐peer‐reviewed or unpublished reports, unspecified date and location of the study, suspicion of duplicate reporting and unreported maternal or perinatal outcomes. No language restrictions were applied. Results We identified a high number of relevant case reports and case series, but only 24 studies, including a total of 324 pregnant women with COVID‐19, met the eligibility criteria and were included in the systematic review. These comprised nine case series (eight consecutive) and 15 case reports. A total of 20 pregnant patients with laboratory‐confirmed COVID‐19 were included in the case reports. In the combined data from the eight consecutive case series, including 211 (71.5%) cases of laboratory‐confirmed and 84 (28.5%) of clinically diagnosed COVID‐19, the maternal age ranged from 20 to 44 years and the gestational age on admission ranged from 5 to 41 weeks. The most common symptoms at presentation were fever, cough, dyspnea/shortness of breath, fatigue and myalgia. The rate of severe pneumonia reported amongst the case series ranged from 0% to 14%, with the majority of the cases requiring admission to the intensive care unit. Almost all cases from the case series had positive computed tomography chest findings. All six and 22 cases that had nucleic‐acid testing in vaginal mucus and breast milk samples, respectively, were negative for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Only four cases of spontaneous miscarriage or termination were reported. In the consecutive case series, 219/295 women had delivered at the time of reporting and 78% of them had Cesarean section. The gestational age at delivery ranged from 28 to 41 weeks. Apgar scores at both 1 and 5 min ranged from 7 to 10. Only eight neonates had birth weight < 2500 g and nearly one‐third of neonates were transferred to the neonatal intensive care...

show abstract

Section: Figure 1 Summarizes the Selection Of Articles For Inclusionmentioning

confidence: 99%

Section: Figure 1 Summarizes the Selection Of Articles For Inclusionmentioning

confidence: 99%

Section: Figure 1 Summarizes the Selection Of Articles For Inclusionmentioning

confidence: 99%

See 1 more Smart Citation

Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome: systematic review

Juan

Gil

Zeng

et al. 2020

Ultrasound in Obstet & Gyne

507

501

View full text Add to dashboard Cite

show abstract

“…Improving the survival and well-being of mothers and newborns is indisputably a global priority, especially during pandemic [5]. Since COVID-19 broke out, there has been plenty of research focused on pregnant women infected with COVID-19 [6][7][8]. For maternal and newborn health, however, a critical question today is not only the extent to which pregnant or postpartum women and newborns are vulnerable to COVID-19 infection but also the degree to which giving a healthy birth in the general pregnant population who are not infected with coronavirus is influenced by lockdown and quarantines.…”

Section: Introductionmentioning

confidence: 99%

The associated factors of cesarean section during COVID-19 pandemic: a cross-sectional study in nine cities of China

Zhang

et al. 2020

Environ Health Prev Med

View full text Add to dashboard Cite

Background Improving and maintaining the health of mothers and newborns is indisputably a global priority, especially during a pandemic. This study intends to examine the factors associated with cesarean section (CS) during lockdown time. Methods A total of 678 women who just gave birth within 7 days were enrolled from maternal and children hospitals in nine cities of China from April to May 2020. The delivery modes and potential influencing factors were investigated. The subgroup analysis and sensitivity analysis were used to examine the association of CS and risk factors among populations with different characteristics and to control for possible confounding, respectively. Results The overall rate of cesarean delivery was 37.3%. In multi-variant model, maternal age > 30 years (OR, 95% CI = 1.71, 1.21–2.41), higher pre-gestational BMI (OR, 95% CI = 1.16, 1.10–1.23), living in regions with confirmed COVID-19 cases > 500 (OR, 95% CI = 2.45, 1.74–3.45), and excess gestational weight gain (OR, 95% CI = 1.73, 1.17–2.55) were associated with cesarean delivery. These trends of associations were not changes in sensitivity analysis and subgroup analysis. Cesarean delivery occurred more in women who got more nutrition instruction during the pandemic period in the univariant model; however, this association showed insignificance in the multiple-variant analysis. Conclusion A high cesarean delivery rate was found in uninfected women who experienced lockdown in their third trimester. During the COVID-19 pandemic, more medical support should be provided in severely affected regions to ensure and promote health in pregnancy.

show abstract

“… 41 48 61 64 75 Although usually respiratory symptoms are seen more in preterm babies due to pulmonary immaturity, in a single case report there were no neonatal complications in a SARS-CoV-2 positive mother who delivered a preterm baby at 29 weeks 5 days by emergency CS for maternal indications. 88 …”

Section: Resultsmentioning

confidence: 99%

COVID-19 in pregnancy: the foetal perspective—a systematic review

Dube

Kar

2020

bmjpo

View full text Add to dashboard Cite

ObjectiveWe aimed to conduct a systematic review of the available literature to determine the effects of confirmed cases of COVID-19 in pregnant women from the foetal perspective by estimation of mother to child transmission, perinatal outcome and possible teratogenicity.MethodsData sources: eligible studies between 1 November 2019 and 10 August 2020 were retrieved from PubMed, Embase, LitCovid, Google Scholar, EBSCO MEDLINE, CENTRAL, CINAHL, MedRXiv, BioRXiv and Scopus collection databases. English language case reports, case series and cohort studies of SARS-CoV-2 confirmed pregnant women with data on perinatal outcome, congenital anomalies and mother to child transmission were analysed.Results38 case reports, 34 cohort and case series describing 1408 neonates were included for evidence acquisition of mother to child transmission. 29 case reports and 31 case series and cohort studies describing 1318 foetuses were included for the evaluation of perinatal outcome and congenital anomalies. A pooled proportion of 3.67% neonates had positive SARS-CoV-2 viral RNA nasopharyngeal swab results and 7.1% had positive cord blood samples. 11.7% of the placenta, 6.8% of amniotic fluid, 9.6% of faecal and rectal swabs and none of the urine samples were positive. The rate of preterm labour was 26.4% (OR=1.45, 95% CI 1.03 to 2.03 with p=0.03) and caesarean delivery (CS) was 59.9% (OR=1.54, 95% CI 1.17 to 2.03 with p=0.002). The most common neonatal symptom was breathing difficulty (1.79%). Stillbirth rate was 9.9 per 1000 total births in babies born to COVID-19 mothers.ConclusionChances of mother to child transmission of the SARS-CoV-2 virus is low. The perinatal outcome for the foetus is favourable. There is increased chances of CS but not preterm delivery.The stillbirth and neonatal death rates are low. There are no reported congenital anomalies in babies born to SARS CoV-2 positive mothers.

show abstract

Pronóstico perinatal y de la paciente embarazada con infección por COVID-19

Cited by 22 publications

References 6 publications

Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome: systematic review

Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome: systematic review

The associated factors of cesarean section during COVID-19 pandemic: a cross-sectional study in nine cities of China

COVID-19 in pregnancy: the foetal perspective—a systematic review

Contact Info

Product

Resources

About